dsm-firmenich in legal action as it alleges its biotin patent technology was infringed
dsm-firmenich claims China-based company, Shengda, is in violation of patent rules in relation to its production of a biotin intermediate.
dsm-firmenich claims China-based company, Shengda, is in violation of patent rules in relation to its production of a biotin intermediate.
The CPG giant recorded high single-digit sales in coffee last year and a strong recovery of out-of-home channels. The company is now increasing its range of plant-based dairy alternatives for the foodservice to offer greater variety and choice to consumers.